Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04655976
Title Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-Small Cell Lung Cancer Who Have Progressed on Prior Anti- Programmed Death-ligand 1 (PD-[L]1) Therapy and Chemotherapy (COSTAR Lung)
Acronym COSTAR Lung
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Cerritos California 90703 United States Details
GSK Investigational Site Fountain Valley California 92708 United States Details
GSK Investigational Site Los Angeles California 90034 United States Details
GSK Investigational Site Oakland California 94611 United States Details
GSK Investigational Site Roseville California 95661 United States Details
GSK Investigational Site San Francisco California 94115 United States Details
GSK Investigational Site San Francisco California 94121 United States Details
GSK Investigational Site Santa Clara California 95051 United States Details
GSK Investigational Site Vallejo California 94589 United States Details
GSK Investigational Site Walnut Creek California 94596 United States Details
GSK Investigational Site Norwich Connecticut 06360 United States Details
GSK Investigational Site Washington District of Columbia 20422 United States Details
GSK Investigational Site Orange City Florida 32763 United States Details
GSK Investigational Site Honolulu Hawaii 96819 United States Details
GSK Investigational Site Iowa City Iowa 52242 United States Details
GSK Investigational Site Edgewood Kentucky 41017 United States Details
GSK Investigational Site Louisville Kentucky 42061 United States Details
GSK Investigational Site Billings Montana 59102 United States Details
GSK Investigational Site Las Vegas Nevada 89144 United States Details
GSK Investigational Site Bronx New York 10468 United States Details
GSK Investigational Site Mineola New York 11501 United States Details
GSK Investigational Site New York New York 10010 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site Northport New York 11768 United States Details
GSK Investigational Site White Plains New York 10601 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15224 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15232 United States Details
GSK Investigational Site Sioux Falls South Dakota 57105 United States Details
GSK Investigational Site Knoxville Tennessee 37916 United States Details
GSK Investigational Site Memphis Tennessee 38104 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Fredericksburg Virginia 22408 United States Details
GSK Investigational Site Tacoma Washington 98405 United States Details
GSK Investigational Site Ciudad Autonoma de Buenos Aires Buenos Aires 1425 Argentina Details
GSK Investigational Site Florida Buenos Aires 1602 Argentina Details
GSK Investigational Site Pergamino Buenos Aires B2700CPM Argentina Details
GSK Investigational Site Cipoletti, Rio Negro Río Negro R8324CVE Argentina Details
GSK Investigational Site Viedma Río Negro R8500ACE Argentina Details
GSK Investigational Site Rosario Santa Fe S2000DBS Argentina Details
GSK Investigational Site Ciudad Autónoma de Buenos Aires C1426ABP Argentina Details
GSK Investigational Site La Rioja F5300COE Argentina Details
GSK Investigational Site Kurralta Park South Australia 5037 Australia Details
GSK Investigational Site South Brisbane South Australia 4101 Australia Details
GSK Investigational Site Hobart Tasmania 7000 Australia Details
GSK Investigational Site Ballarat Victoria 3350 Australia Details
GSK Investigational Site Melbourne Victoria 3004 Australia Details
GSK Investigational Site Aalst 9300 Belgium Details
GSK Investigational Site Hasselt 3500 Belgium Details
GSK Investigational Site Kortrijk 8500 Belgium Details
GSK Investigational Site Ondina Bahia 40170-110 Brazil Details
GSK Investigational Site Fortaleza Ceará 60336-232 Brazil Details
GSK Investigational Site Porto Alegre Rio Grande Do Sul 90610000 Brazil Details
GSK Investigational Site Blumenau Santa Catarina 89010340 Brazil Details
GSK Investigational Site Rio de Janeiro 22061080 Brazil Details
GSK Investigational Site Rio de Janeiro 22250-905 Brazil Details
GSK Investigational Site São Paulo 04014-002 Brazil Details
GSK Investigational Site Kingston Ontario K7L 2V7 Canada Details
GSK Investigational Site Oshawa Ontario L1G 2B9 Canada Details
GSK Investigational Site Sudbury Ontario P3E 5J1 Canada Details
GSK Investigational Site Greenfield Park Quebec J4V 2H1 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Helsinki 00180 Finland Details
GSK Investigational Site Kuopio 70210 Finland Details
GSK Investigational Site Tampere 33520 Finland Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Créteil Cedex 94010 France Details
GSK Investigational Site Grenoble cedex 9 38043 France Details
GSK Investigational Site Marseille 13009 France Details
GSK Investigational Site Nice Cedex 2 06189 France Details
GSK Investigational Site Quimper cedex 29107 France Details
GSK Investigational Site Rennes Cedex 9 35033 France Details
GSK Investigational Site Tours cedex 9 37044 France Details
GSK Investigational Site Heidelberg Baden-Wuerttemberg 69126 Germany Details
GSK Investigational Site Karlsruhe Baden-Wuerttemberg 76137 Germany Details
GSK Investigational Site Augsburg Bayern 86156 Germany Details
GSK Investigational Site Muenchen Bayern 80336 Germany Details
GSK Investigational Site Muenchen Bayern 81925 Germany Details
GSK Investigational Site Frankfurt am Main Hessen 60590 Germany Details
GSK Investigational Site Frankfurt Hessen 60488 Germany Details
GSK Investigational Site Oldenburg Niedersachsen 26121 Germany Details
GSK Investigational Site Bonn Nordrhein-Westfalen 53113 Germany Details
GSK Investigational Site Essen Nordrhein-Westfalen 45147 Germany Details
GSK Investigational Site Koeln Nordrhein-Westfalen 51109 Germany Details
GSK Investigational Site Halle Sachsen-Anhalt 06120 Germany Details
GSK Investigational Site Dresden Sachsen 01307 Germany Details
GSK Investigational Site Bad Berka Thueringen 99437 Germany Details
GSK Investigational Site Berlin 12200 Germany Details
GSK Investigational Site Athens 115 27 Greece Details
GSK Investigational Site Athens 11526 Greece Details
GSK Investigational Site Athens 11528 Greece Details
GSK Investigational Site Athens 12462 Greece Details
GSK Investigational Site Larissa 41100 Greece Details
GSK Investigational Site Patras 26504 Greece Details
GSK Investigational Site Thessaloniki 55236 Greece Details
GSK Investigational Site Thessaloniki 570 01 Greece Details
GSK Investigational Site Thessaloniki 57010 Greece Details
GSK Investigational Site Avellino Campania 83100 Italy Details
GSK Investigational Site Napoli Campania 80131 Italy Details
GSK Investigational Site Milano Lombardia 20132 Italy Details
GSK Investigational Site Milano Lombardia 20133 Italy Details
GSK Investigational Site Monza Lombardia 20900 Italy Details
GSK Investigational Site Torrette (AN) Marche 60126 Italy Details
GSK Investigational Site Orbassano (TO) Piemonte 10043 Italy Details
GSK Investigational Site Firenze Toscana 50134 Italy Details
GSK Investigational Site Siena Toscana 53100 Italy Details
GSK Investigational Site Perugia Umbria 06156 Italy Details
GSK Investigational Site Kyoto 612-8555 Japan Details
GSK Investigational Site Miyagi 981-1293 Japan Details
GSK Investigational Site Osaka 591-8555 Japan Details
GSK Investigational Site Yamaguchi 755-0241 Japan Details
GSK Investigational Site Busan 49241 Korea, Republic of Details
GSK Investigational Site Cheongju-si, Chungcheongbuk-do 28644 Korea, Republic of Details
GSK Investigational Site Daegu-si 42601 Korea, Republic of Details
GSK Investigational Site Gyeonggi-do 10408 Korea, Republic of Details
GSK Investigational Site Seongnam-si, Gyeonggi-do 13620 Korea, Republic of Details
GSK Investigational Site Seoul 03722 Korea, Republic of Details
GSK Investigational Site Seoul 05505 Korea, Republic of Details
GSK Investigational Site Seoul 06351 Korea, Republic of Details
GSK Investigational Site Seoul 08308 Korea, Republic of Details
GSK Investigational Site Suwon-Si 443-721 Korea, Republic of Details
GSK Investigational Site Benito Juarez Ciudad De Mexico 03810 Mexico Details
GSK Investigational Site Mexico City Ciudad De Mexico 06700 Mexico Details
GSK Investigational Site Mexico Ciudad De Mexico 03100 Mexico Details
GSK Investigational Site Guadalajara Jalisco 44280 Mexico Details
GSK Investigational Site Monterrey Nuevo León 64460 Mexico Details
GSK Investigational Site Mexico City CP 14080 Mexico Details
GSK Investigational Site Puebla 72560 Mexico Details
GSK Investigational Site Amersfoort 3813 TZ Netherlands Details
GSK Investigational Site Enschede 7512 KZ Netherlands Details
GSK Investigational Site Groningen 9713 GZ Netherlands Details
GSK Investigational Site Harderwijk 3844 DG Netherlands Details
GSK Investigational Site Nijmegen 6525 GA Netherlands Details
GSK Investigational Site Utrecht 3543 AZ Netherlands Details
GSK Investigational Site Zwolle 8025 AB Netherlands Details
GSK Investigational Site Bydgoszcz 85-796 Poland Details
GSK Investigational Site Gdynia 81-519 Poland Details
GSK Investigational Site Lodz 90-338 Poland Details
GSK Investigational Site Olsztyn 10-357 Poland Details
GSK Investigational Site Pila 64-920 Poland Details
GSK Investigational Site Poznan 60-693 Poland Details
GSK Investigational Site Bucuresti 021389 Romania Details
GSK Investigational Site Craiova 200347 Romania Details
GSK Investigational Site Craiova 200385 Romania Details
GSK Investigational Site Otopeni 075100 Romania Details
GSK Investigational Site Timisoara 300239 Romania Details
GSK Investigational Site Chelyabinsk 454048 Russian Federation Details
GSK Investigational Site Moscow 143423 Russian Federation Details
GSK Investigational Site Pushkin 196603 Russian Federation Details
GSK Investigational Site Saint-Petersburg 197022 Russian Federation Details
GSK Investigational Site Badalona 08916 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Burgos 09006 Spain Details
GSK Investigational Site Cordoba 140044 Spain Details
GSK Investigational Site La Coruña 15006 Spain Details
GSK Investigational Site Las Palmas De Gran Canaria 35016 Spain Details
GSK Investigational Site Madrid 28007 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
GSK Investigational Site Majadahonda (Madrid) 28222 Spain Details
GSK Investigational Site Malaga 29010 Spain Details
GSK Investigational Site Valencia 46026 Spain Details
GSK Investigational Site Gävle SE-801 87 Sweden Details
GSK Investigational Site Solna 171 64 Sweden Details
GSK Investigational Site Uppsala SE-751 85 Sweden Details
GSK Investigational Site Hsinchu City 300 Taiwan Details
GSK Investigational Site New Taipei City 23561 Taiwan Details
GSK Investigational Site Taichung 407 Taiwan Details
GSK Investigational Site Taipei City 11217 Taiwan Details
GSK Investigational Site Bangkok 10210 Thailand Details
GSK Investigational Site Dusit 10300 Thailand Details
GSK Investigational Site Hat Yai 90110 Thailand Details
GSK Investigational Site Khlong Luang 12120 Thailand Details
GSK Investigational Site Muang 40002 Thailand Details
GSK Investigational Site Adana 1120 Turkey Details
GSK Investigational Site Antalya 07020 Turkey Details
GSK Investigational Site Izmir 35600 Turkey Details
GSK Investigational Site Edinburgh EH4 2XU United Kingdom Details
GSK Investigational Site London SE1 9RT United Kingdom Details
GSK Investigational Site London W1G 6AD United Kingdom Details
GSK Investigational Site Manchester M20 4BX United Kingdom Details
GSK Investigational Site Whitchurch, Cardiff CF14 2TL United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field